amputation in ESRD compared with non-ESRD patients and by the 25% amputation rate of diabetic kidney transplant recipients within 5 years of transplantation. 
| MATERIALS AND METHODS

| Database and patient characteristics
This is a retrospective study of all patients in the Vascular Quality 
| Outcomes and statistical analyses
Baseline patient characteristics were compared between renal transplant and nontransplant patients by using the Pearson χ 2 and Fisher exact tests to report counts and percentages and the Student t test to report mean and standard error values. To account for the proportional difference between the 2 groups, we performed coarsened exact matching with the ratio of many to 1. 11 Matching was performed by using factors identified as significantly different in univariate analysis, which were age, Hispanic ethnicity, mobility status (wheelchair bound or bedridden vs mobile), hypertension, diabetes, smoking status (history of or current smoker vs never smoker), congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), CKD stratified by glomerular filtration rate (GFR), the with survival data used in analyses of up to 4 years of follow-up.
All analyses were performed by using Stata 14.1 statistical software (StataCorp, College Station, TX), and statistical significance was accepted at P < .05. To account for imbalances in the sizes of the transplant and nontransplant populations, coarsened exact matching of many-to-1 and 1-to-1 were performed, which confirmed that transplant patients were younger, were less freely ambulatory, had a higher incidence of diabetes and CHF, presented more frequently with CLI, and were more likely to receive vein conduits and require a more-distal level of bypass (Table 2 ).
| RESULTS
| Study population
| Primary patency outcomes
Risk factors associated with loss of primary patency on univariable and multivariable analyses were female sex, history of previous bypass, use of vein other than the GSV, and CLI on presentation (Table 3) . Compared with femoral-popliteal bypass, a more-distal bypass, femoral-tibial, was associated with primary patency loss.
Importantly, a history of renal transplantation was not associated with an increased risk of primary patency loss. All results were confirmed in multivariable analysis by using a matched many-to-1 cohort as well (Table S1 ).
Primary patency rates were similar between transplant and nontransplant patients at 1 year (80.8% vs 77.5%) and at 2 years (67.9%
vs 63.7%, P = .079, Table 5 ). Likewise, primary-assisted patency ASA, American Society of Anesthesiology risk classification; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; GFR, glomerular filtration rate; GSV, greater saphenous vein; SD, standard deviation.
rates were similar between transplant and nontransplant patients at 1 year (93.8% vs 92.0%) and at 2 years (75.4% vs 83.8%, P = .86, Table 5 ).
| Amputation-free survival outcomes
History of kidney transplantation was not associated with an increased risk of limb loss or death after lower extremity bypass on univariable or multivariable analysis (Table 4 ) or in a many-to-1 matched cohort (Table S1) (Table 4) .
Amputation-free survival was higher for nontransplant compared with transplant patients at 1 year (82.4% vs 75.3%) and at 2 years (68.8% vs 58.2%, P = .0060) ( Table 5 ). Cox regression analysis stratifying by level of bypass demonstrated that this difference between transplant and nontransplant patients was driven by those with the distal-most level of bypass, or popliteal-tibial or tibial-distal, rather than those with more-proximal bypasses (Tables S2, S3 ).
| Overall survival outcomes
Overall survival after infrainguinal bypass was similar between transplant and nontransplant patients at 1 month (98.2% vs 98.2%), 1 year (91.4% vs 91.1%), 2 years (84.6% vs 87.2%), and 4 years (75.9% vs 79.6%) (P = .35, Table 6 ).
T A B L E 2 Baseline characteristics after coarsened exact matching of transplant and nontransplant patients undergoing lower extremity bypass Transplant patients were more likely to require a wheelchair or to be bedridden preoperatively, which may be related to their higher prevalence of a prior contralateral major amputation. Not surprisingly, a higher proportion of transplant patients undergoing bypass had CLI 
| DISCUSSION
T A B L E 3 Univariable and multivariable
Cox proportional hazard analysis for predictors of primary patency loss (87.6% vs 69.0%), as most centers do not offer revascularization for patients with ESRD and only claudication. 6 Transplant patients were more likely to undergo a more-distal level of bypass and were more likely to receive a vein conduit, which may be due to surgeon preference to avoid prosthetic material in these immunosuppressed patients.
We found that 1-and 2-year primary and primary assisted patency rates were similar between transplant and nontransplant patients, despite the fact that transplant patients had a higher prevalence of comorbid conditions, more frequently presented with CLI, and underwent revascularization of more-distal arteries. Our demonstration of revascularization results that are as good as those of nontransplant, non-ESRD patients suggests that a bias against aggressive attempts at limb salvage in transplant patients is not warranted.
Our finding of lower limb salvage rates in transplant patients, despite equivalent primary patency rates, may be reflective of observations that 42% of transplant 13 and as many as 100% of ESRD patients 10 who ultimately require amputation have it performed in the setting of a patent bypass graft. This suggests that factors in addition to ischemia play a key role in limb loss in this population, such as poor wound healing and infection related to diabetes, renal failure, immunosuppression, and microvascular disease. 6 Poorer outcomes have been demonstrated in patients with ESRD with extensive foot ulceration at the time of revascularization, with ulcers >2 cm, gangrene extending proximal to the web space, or deep heel defects conferring higher risk. 10,14-16 Some authors have advocated that primary amputation may be more appropriate in these select patients. Moreover, the higher rate of limb loss seen in the Few studies have rigorously evaluated baseline demographic or medical characteristics for predictors of primary patency and amputation-free survival. We found that female sex was associated with increased risk of primary patency loss, while age and diabetes were associated with increased risk of limb loss. These factors have been implicated in prior studies, although the reasons are not well understood.
Possible contributing factors include a distinct distribution and severity of atherosclerotic disease in diabetic patients and that women tend to present at an older age and with more-advanced disease.
17-20
History of a previous bypass, a more-distal bypass, and the pres- One-year, 2-year, and 4-year overall survival rates after infrainguinal bypass were no different between transplant and nontransplant patients. Our overall survival of 75.9% at 4 years is similar to that of a smaller study of 60 transplant patients that demonstrated a survival of 84.6% at 3 years and of 67.4% at 5 years. 13 These findings are in stark contrast to those of infrainguinal bypass procedures in dialysis patients who carry a dismal 3-year survival of 18%. 22 These results suggest that renal transplantation can ameliorate poor outcomes after infrainguinal revascularization. This is further supported by evidence from patients with renal allograft dysfunction who have significantly decreased survival after lower extremity revascularization, with rates that approximate those of dialysis patients. 13 Several limitations of this study must be considered, including notably the inherent drawbacks of a retrospective analysis. All patients in the VQI database undergoing infrainguinal bypass between 2003 and 2016 were evaluated for this study; however, there were significantly more nontransplant patients available for analysis. In an attempt to reduce the imbalance between the groups, coarsened exact matching was used. Differences in outcomes across studies may reflect variations in the included populations, such as the number of diabetic patients or smokers, as well as in the indications for intervention, such as claudication, ulceration, or gangrene.
Further, there are likely differences between studies in the type of revascularization procedures performed, such as level of bypass, type of conduit, angioplasty, and stenting. Given recent advancements in endovascular procedures, future studies comparing the results of endovascular interventions with the results of bypass will be essential. Nonetheless, this is the largest study to date of limb salvage in transplant patients and the only one that directly compares a transplant with a nontransplant cohort.
In conclusion, the management of lower extremity ischemia in transplant patients is not well defined. Poor outcomes in patients with ESRD should not be extrapolated to the renal transplant population.
We found that 2-year primary and primary assisted patency rates were equivalent between transplant and nontransplant patients. 
DISCLOSURE
